Logo image of RDZN

ROADZEN INC (RDZN) Stock Fundamental Analysis

NASDAQ:RDZN - Nasdaq - VGG7606H1082 - Common Stock

1.92  +0.2 (+11.63%)

Fundamental Rating

1

Overall RDZN gets a fundamental rating of 1 out of 10. We evaluated RDZN against 285 industry peers in the Software industry. Both the profitability and financial health of RDZN have multiple concerns. RDZN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDZN had negative earnings in the past year.
RDZN had a negative operating cash flow in the past year.
RDZN had negative earnings in 4 of the past 5 years.
In the past 5 years RDZN always reported negative operating cash flow.
RDZN Yearly Net Income VS EBIT VS OCF VS FCFRDZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

RDZN has a worse Return On Assets (-462.51%) than 98.21% of its industry peers.
Industry RankSector Rank
ROA -462.51%
ROE N/A
ROIC N/A
ROA(3y)-57.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDZN Yearly ROA, ROE, ROICRDZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Gross Margin of RDZN (57.09%) is worse than 64.16% of its industry peers.
RDZN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDZN Yearly Profit, Operating, Gross MarginsRDZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

RDZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDZN has more shares outstanding
The debt/assets ratio for RDZN is higher compared to a year ago.
RDZN Yearly Shares OutstandingRDZN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
RDZN Yearly Total Debt VS Total AssetsRDZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -23.05, we must say that RDZN is in the distress zone and has some risk of bankruptcy.
RDZN has a worse Altman-Z score (-23.05) than 94.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.05
ROIC/WACCN/A
WACC11.11%
RDZN Yearly LT Debt VS Equity VS FCFRDZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.38 indicates that RDZN may have some problems paying its short term obligations.
RDZN has a Current ratio of 0.38. This is amonst the worse of the industry: RDZN underperforms 95.34% of its industry peers.
A Quick Ratio of 0.38 indicates that RDZN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.38, RDZN is doing worse than 95.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
RDZN Yearly Current Assets VS Current LiabilitesRDZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

RDZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -353.56%.
RDZN shows a strong growth in Revenue. In the last year, the Revenue has grown by 200.24%.
EPS 1Y (TTM)-353.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.83%
Revenue 1Y (TTM)200.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.25%

3.2 Future

The Earnings Per Share is expected to grow by 37.84% on average over the next years. This is a very strong growth
Based on estimates for the next years, RDZN will show a very strong growth in Revenue. The Revenue will grow by 39.88% on average per year.
EPS Next Y49.57%
EPS Next 2Y37.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.83%
Revenue Next 2Y21.36%
Revenue Next 3Y41.48%
Revenue Next 5Y39.88%

3.3 Evolution

RDZN Yearly Revenue VS EstimatesRDZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
RDZN Yearly EPS VS EstimatesRDZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RDZN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RDZN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDZN Price Earnings VS Forward Price EarningsRDZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RDZN Per share dataRDZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

RDZN's earnings are expected to grow with 37.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RDZN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROADZEN INC

NASDAQ:RDZN (1/22/2025, 10:40:10 AM)

1.92

+0.2 (+11.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners18.95%
Inst Owner Change9.44%
Ins Owners2.73%
Ins Owner Change0.94%
Market Cap135.24M
Analysts82.5
Price Target6.12 (218.75%)
Short Float %3.05%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-44.26%
Min EPS beat(2)-98.88%
Max EPS beat(2)10.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.45%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)-3.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-34.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.91
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.97
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.66
BVpS-0.48
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -462.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.09%
FCFM N/A
ROA(3y)-57.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -23.05
F-Score3
WACC11.11%
ROIC/WACCN/A
Cap/Depr(3y)50.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-353.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.83%
EPS Next Y49.57%
EPS Next 2Y37.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)200.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.25%
Revenue Next Year-8.83%
Revenue Next 2Y21.36%
Revenue Next 3Y41.48%
Revenue Next 5Y39.88%
EBIT growth 1Y-822.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-642.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-622.8%
OCF growth 3YN/A
OCF growth 5YN/A